THE EFFECTS OF ERYTHROMYCIN ON THE ABSORPTION AND DISPOSITION KINETICS OF THEOPHYLLINE

被引：27

作者：

BRANIGAN, TA

ROBBINS, RA

CADY, WJ

NICKOLS, JG

UEDA, CT

机构：

[1] UNIV NEBRASKA,MED CTR,COLL PHARM,DEPT PHARM PRACTICE,OMAHA,NE 68105

[2] UNIV NEBRASKA,MED CTR,COLL PHARM,DEPT PHARMACEUT,OMAHA,NE 68105

[3] UNIV NEBRASKA,MED CTR,COLL MED,DEPT INTERNAL MED,DIV PULM,OMAHA,NE 68105

[4] UNIV NEBRASKA,MED CTR,CTR CARDIOVASC,OMAHA,NE 68105

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 21卷 / 02期

关键词：

D O I：

10.1007/BF00637511

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：115 / 120

页数：6

共 11 条

[1]

CUMMINS LH, 1977, PEDIATRICS, V59, P144

[2] LACK OF EFFECT OF INTRAVENOUS ERYTHROMYCIN LACTOBIONATE ON THEOPHYLLINE CLEARANCE [J].

KIMELBLATT, BJ ;

SLAUGHTER, RL .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1980, 65 (04) :313-314

[3] ADMINISTRATION OF ERYTHROMYCIN TO PATIENTS ON THEOPHYLLINE [J].

KOZAK, PP ;

CUMMINS, LH ;

GILLMAN, SA .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1977, 60 (02) :149-151

[4] PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OF ORAL THEOPHYLLINE CAPSULES [J].

LESKO, LJ ;

CANADA, AT ;

EASTWOOD, G ;

WALKER, D ;

BROUSSEAU, DR .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (11) :1392-1394

[5]

METZLER CM, 1974, BIOMETRICS, V30, P562

[6]

PENG GW, 1976, RES COMMUN CHEM PATH, V15, P341

[7]

PFEIFER HJ, 1979, CLIN PHARMACOL THER, V26, P36

[8] THEOPHYLLINE BIOAVAILABILITY FOLLOWING CHRONIC DOSING OF AN ELIXIR AND 2 SOLID DOSAGE FORMS [J].

SHEN, DD ;

FIXLEY, M ;

AZARNOFF, DL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (07) :916-919

[9] INHIBITION OF THEOPHYLLINE CLEARANCE BY TROLEANDOMYCIN [J].

WEINBERGER, M ;

HUDGEL, D ;

SPECTOR, S ;

CHIDSEY, C .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1977, 59 (03) :228-231

[10] INFLUENCE OF FORMULATION ON BIOAVAILABILITY OF THEOPHYLLINE [J].

WELLING, PG ;

DOMORADZKI, J ;

SIMS, JA ;

REED, CE .

JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (01) :43-50

← 1 2 →